ANAB

Anaptysbio Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↑ 8/10
  • Value↓ 1/10
Anaptysbio sales and earnings growth
ANAB Growth
Good
  • Revenue Y/Y↑ 157.01%
  • EPS Y/Y↑ 91.02%
  • FCF Y/Y↑ 114.45%
Anaptysbio gross and profit margin trends
ANAB Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -5.60%
  • ROIC 5Y↓ -18.99%
Anaptysbio net debt vs free cash flow
ANAB Risk
Poor
  • Debt / Equity↑ 7.8
  • Debt / FCF↓ 2.7
  • Interest coverage↑ 999.0

Anaptysbio stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Biotechnology stocks ↗